Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.

$10.08
0 (0%)
NASDAQ Global Select
USD, US
Medical - Devices

TMCI Price Chart

Basic
Market Cap$627.95M
Price$10.08
52 Week Range3.92-15.44
Beta0.76
Margins
Gross Profit Margin80.25%
Operating Profit Margin-24.81%
Net Profit Margin-25.13%
Valuation (TTM)
P/E Ratio-7.98
Price to Sales Ratio2.01
Price to Book Ratio4.02
PEG Ratio-1.44

Industry

Medical - Devices

Sector

Healthcare

Full-Time Employees

516

IPO Date

2021-04-23T00:00:00.000Z

Description

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Phone

904 373 5940

Address

203 Fort Wade Road, Ponte Vedra, FL, 32081, US

CIK

0001630627